leadf
logo-loader
viewBiotechnology Innovation Organization (BIO)

SFA Therapeutics developing its psoriasis therapy to showcase its anti-inflammatory platform

SFA Therapeutics, Inc CEO Dr. Ira Spector sat down with Proactive at the BIO Investor Forum in San Francisco. The Pennsylvania-based company, using microbiome-derived metabolites as drugs, is advancing its oral treatment for psoriasis into Phase 2 clinical studies.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold adds 2nd drill rig as company identifies new high-grade veins

Cabral Gold (CVE: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive Vancouver with news the company has identified at least six new NE trending high-grade veins in the Machichie SW area located immediately north of the MG deposit. Carter telling Proactive what had led them...

2 days, 9 hours ago

2 min read